Cellebrite DI (CLBT) Long-Term Investments (2022 - 2026)

Cellebrite DI has reported Long-Term Investments for 5 years, with the latest figure at $103.2 million in Q2 2026.

• On a quarterly basis, Long-Term Investments rose 20.46% year-over-year to $103.2 million in Q2 2026; TTM through Jun 2026 was $103.2 million, a 20.46% increase from a year earlier, with the FY2025 full-year figure at $98.0 million, up 167.64% from the prior year.
• Long-Term Investments was $103.2 million for Q2 2026 at Cellebrite DI, up from $98.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $103.2 million in Q2 2026, with the low at $7.3 million in Q2 2023.
• Average Long-Term Investments over 5 years is $51.7 million, with a median of $36.6 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments slumped 68.04% in 2023, then jumped 731.19% in 2024.
• Over 5 years, Long-Term Investments stood at $22.1 million in 2022, then surged by 30.44% to $28.9 million in 2023, then rose by 26.83% to $36.6 million in 2024, then soared by 167.64% to $98.0 million in 2025, then advanced by 5.33% to $103.2 million in 2026.
• The last three Long-Term Investments figures came in at $103.2 million (Q2 2026), $98.0 million (Q4 2025), and $85.7 million (Q2 2025), per Business Quant data.